Literature DB >> 9787947

Pregnancies following liver transplantation--how safe are they? A report of 19 cases under cyclosporine A and tacrolimus.

N Rayes1, R Neuhaus, M David, T Steinmüller, W O Bechstein, P Neuhaus.   

Abstract

The number of pregnancies following liver transplantation is increasing due to better patient and graft survival and quality of life. Out of 156 women of a reproductive age, there were 19 pregnancies in 16 women, 12 on CsA and seven on tacrolimus, which occurred between 7/92 and 1/97. The median age of the women was 27.9 yr, median time after transplantation 33 months. There were four spontaneous and two induced abortions in the first trimenon. Ten women delivered ten healthy babies; three newborns had problems (alcoholic embryopathy due to recurrent alcohol abuse of his mother, pneumonia, weight < 2000 g). In eight women mostly mild complications were observed, such as hypertension (n = 5), nonspecific elevation of liver enzymes (n = 2), infection (n = 3) and premature labor (n = 1). Mean gestational age was 39 wk and mean birth weight 2900 g. One case of prematurity and three cases of growth retardation occurred. Cesarean sections were performed in 7 patients (54%) for maternal hypertension (n = 2), presumed fetal hypoxia (n = 4) and breech position (n = 1). All children are normally developed, the oldest being 5 yr old. Although experience with tacrolimus is limited, pregnancies following liver transplantation carry an acceptable risk if carefully monitored by an experienced team of transplant surgeons and obstetricians.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787947

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  6 in total

1.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 2.  Pregnancy following liver transplantation: review of outcomes and recommendations for management.

Authors:  Kuljit S Parhar; Paul S Gibson; Carla S Coffin
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

3.  Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years.

Authors:  Ashokkumar B Jain; J Reyes; Amadeo Marcos; G Mazariegos; Bijan Eghtesad; Paulo A Fontes; Thomas V Cacciarelli; J Wallis Marsh; Michael E de Vera; Ann Rafail; Thomas E Starzl; John J Fung
Journal:  Transplantation       Date:  2003-09-15       Impact factor: 4.939

4.  ACG Clinical Guideline: Liver Disease and Pregnancy.

Authors:  Tram T Tran; Joseph Ahn; Nancy S Reau
Journal:  Am J Gastroenterol       Date:  2016-02-02       Impact factor: 10.864

5.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

6.  Pregnancy Outcomes Following Pediatric Liver Transplantation: A Single-Center Experience in Japan.

Authors:  Itsuki Naya; Yukihiro Sanada; Takumi Katano; Go Miyahara; Yuta Hirata; Naoya Yamada; Noriki Okada; Yasuharu Onishi; Yasunaru Sakuma; Naohiro Sata
Journal:  Ann Transplant       Date:  2020-06-09       Impact factor: 1.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.